3 Bethesda Metro Center
Education and Government Service
University of Minnesota, College of Liberal Arts
University of Minnesota, Graduate School
Fellow, National Council on Alcoholism
University of Minnesota
National Institute on Drug Abuse, NIH, Pharmacologist, Chief, Clinical Pharmacology Research Branch
Understanding the biological basis of drug addiction to improve substance abuse prevention, treatment and policy, with a particular emphasis on tobacco and nicotine. Contributing to the scientific foundation for public health policy nationally and internationally for a broad ranges of diseases but with emphasis on addictions.
Click here for a Hopkins Brain Wise Newsletter article about Dr. Henningfield's work
Benowitz, N.L. and Henningfield, J.E. Establishing a nicotine threshold for addiction. New England Journal of Medicine, 331 (2): 123-125, 1994.
Henningfield, J.E., Kozlowski, L.T. and Benowitz, N.L. A proposal to develop meaningful labeling for cigarettes. Journal of the American Medical Association, 272 (4): 312-314, 1994.
Henningfield, J.E. Nicotine medications for smoking cessation. New England Journal of Medicine, 333: 1196-1203, 1995.
Henningfield, J.E. and Zeller, M. Could science-based regulation make tobacco products less addictive. Yale Journal of Health Policy, Law and Ethics, Vol. III (Winter), Issue 1: 127-138, 2002.
Henningfield, J.E., Moolchan, E.T. and Zeller, M. Regulatory strategies to reduce tobacco addiction in youth. Tobacco Control, 12 (Supl. 1): i14-i24, 2003.